Ethica Corporate Finance advised Specchiasol, portfolio company of Whitebridge Investments, in the acquisition of the one hundred percent of NAMED. The shareholders of NAMED will reinvest in the combined entity retaining a minority stake, as well as their managerial role within the Group.
Specchiasol is an Italian distributor of own-branded food supplements and medical devices through the pharmacy and herbalist channels, with a capillary presence both in Italy and abroad. The company boasts a wide portfolio of 360 products and relies on 54 brands. In 2020 Whitebridge Investments acquired the company from the founding family.
Founded in 1988 by the Canova family, NAMED is active in the commercialization of food supplements and medical devices in the Italian pharmacy channel. NAMED distributes own branded products as well as third party products, relying on long-lasting distribution agreements with top-flight international brands.
The deal will create a leading player in the nutraceuticals industry with ca. €80 mln revenues and more than 250 employees, with a top tier positioning both in Italy and abroad.